This website uses cookies to improve your browsing experience. Please read our Privacy Policy for more information on what information we gather and how it is used.
Treatment Candidate

IVIG

Background

IVIG, commonly used for autoimmune and immunodeficiency treatments, may help regulate immune function in long COVID patients.

Mechanism of Action

  • IVIG: Provides a broad array of antibodies, which may help modulate immune responses and reduce inflammation (IVIG Study).

Pros and Cons

  • Pros: Known for immunomodulatory effects, which may benefit inflammatory symptoms.
  • Cons: Requires IV administration and carries risks of thrombosis and infusion reactions.

References

  1. IVIG Study
Stage
Pre-clinical
Category
Monoclonal antibody
Ranking
7
Community Rating
5
Lead Researcher
Researcher
(No laboratory information available)
Laboratory
Laboratory
(No laboratory information available)
Funding
$
(No laboratory information available)

Join our community discussion and help us evaluate other treatment candidates

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus ut venenatis enim. Suspendisse eu leo ipsum. Phasellus faucibus lorem sed mi varius pellentesque. Mauris vel elit tincidunt, pharetra arcu venenatis, mattis nisi.